StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Dermapharm Holding SE
XETRA:DMP.DE
Sector
Location
Market Cap
USD 2.23 B
Share Price
USD 41.44
Avg Daily Volume
27,081
Change (1 day)
1.32%
Change (1 year)
7.77%
Change (YTD)
2.37%
Dermapharm Holding SE Total Liabilities for the year ending December 31, 2024: USD 1.52 B
Dermapharm Holding SE Total Liabilities is USD 1.52 B for the year ending December 31, 2024, a -14.54% change year over year. Total liabilities are the total amount of a company's debts and other obligations.
-
Dermapharm Holding SE Total Liabilities for the year ending December 31, 2023 was USD 1.78 B, a 89.32% change year over year.
-
Dermapharm Holding SE Total Liabilities for the year ending December 31, 2022 was USD 941.92 M, a -8.79% change year over year.
-
Dermapharm Holding SE Total Liabilities for the year ending December 31, 2021 was USD 1.03 B, a -6.05% change year over year.
-
Dermapharm Holding SE Total Liabilities for the year ending December 31, 2020 was USD 1.10 B, a 28.81% change year over year.
Competitors
Johnson & Johnson
USD 155.92
JNJ
+3.17
2.08%
Divi's Laboratories Limited
USD 80.22
DIVISLAB.NS
+0.13
0.17%
ALK-Abelló A/S
USD 29.64
ALK-B.CO
+0.19
0.66%
Nahdi Medical Company
USD 34.24
4164.SR
+0.25
0.72%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.11
JBCHEPHARM.NS
-0.11
-0.58%
Rohto Pharmaceutical Co.,Ltd.
USD 14.41
4527.T
+0.14
0.97%
Hypera S.A.
USD 5.07
HYPE3.SA
+0.07
1.41%
Almirall, S.A.
USD 12.56
ALM.MC
+0.02
0.16%
Organon & Co.
USD 10.05
OGN
+0.37
3.82%
Caplin Point Laboratories Limited
USD 22.91
CAPLIPOINT.NS
-0.43
-1.83%
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Key Data
| Date | Total Liabilities | Shareholders' Equity | Cash and Short-Term Investments | Receivables |
|---|
Competitors
Johnson & Johnson
USD 155.92
JNJ
+3.17
2.08%
Divi's Laboratories Limited
USD 80.22
DIVISLAB.NS
+0.13
0.17%
ALK-Abelló A/S
USD 29.64
ALK-B.CO
+0.19
0.66%
Nahdi Medical Company
USD 34.24
4164.SR
+0.25
0.72%
J. B. Chemicals & Pharmaceuticals Limited
USD 19.11
JBCHEPHARM.NS
-0.11
-0.58%
Rohto Pharmaceutical Co.,Ltd.
USD 14.41
4527.T
+0.14
0.97%
Hypera S.A.
USD 5.07
HYPE3.SA
+0.07
1.41%
Almirall, S.A.
USD 12.56
ALM.MC
+0.02
0.16%
Organon & Co.
USD 10.05
OGN
+0.37
3.82%
Caplin Point Laboratories Limited
USD 22.91
CAPLIPOINT.NS
-0.43
-1.83%
Eli Lilly and Company
USD 775.90
LLY
-3.63
-0.47%
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%